Top Biotech Stocks – CVM, ENMD, CERS
Top Biotech Stocks
Dallas, TX 11/12/2009 07:02 PM GMT (TransWorldNews)
We Pick Penny Stocks alerts investors on Top Stocks to Watch. Subscribe to FREE Stock Market Alerts by visiting http://www.wepickpennystocks.com/
CEL-SCI Corporation (AMEX:CVM) surged 3.04% to $1.36 on a massive volume of 3.79 million shares. The stock has a 52-week range of $0.14-$2.10. So far in the last six months trade the stock has rallied over 334%. CEL-SCI Corporation, is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day.
EntreMed, Inc. (NASDAQ:ENMD) notched up 10.84% to $1.43 on a massive volume of 1.61 million shares. The stock today also touched a new 52 week high at $1.53. Till date in this year the stock has rallied over 782%. EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them.
Cerus Corporation (NASDAQ:CERS) spurted 11.24% is trading at $2.46 with a high volume of 916k shares. The stock has a 52-week range of $0.55-$3.57. Cerus Corporation, is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion.
ABOUT WePickPennyStocks.com
It is a leading stock web site that provides free stock alerts on stocks that are poised to make big gains. We also track penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us by email given below.
info[@]wepickpennystocks.com
www.wepickpennystocks.com


Email Article to a friend
|
View Profile
Visit Blogs
|

NEWS ALERTS
Receive alerts for
CVM
to your inbox.
Sign up for TransWorldNews Alerts

TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
